Covaxin gets emergency use approval from DCGI for children above 12 years

Covaxin gets emergency use approval from DCGI for children above 12 years Bharat Biotech informed that Covaxin is documented with excellent safety and immunogenicity data readouts in children https://ift.tt/eA8V8J

Comments

Popular posts from this blog

SC transfers PIL seeking implementation of law on mental health care to NHRC

Hospital-insurer conflict: Will latest circular by NMC help in reducing the pain of health insurance policyholders?

Over 9.19 crore hospital admissions facilitated under Ayushman Bharat since 2018